Activation of microglia and p38 mitogen-activated protein kinase in the dorsal column nucleus contributes to tactile allodynia following peripheral nerve injury

Neuroscience

Volumn 153, Issue 4, 2008, Pages 1245-1255

  Terayama, R ^a   Omura, S ^a,b   Fujisawa, N ^a   Yamaai, T ^a   Ichikawa, H ^a   Sugimoto, T ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b ASAHI College of Medical Art and Sciences   (Japan)

Author keywords

behavior; gracile nucleus; immunohistochemistry; neuropathic pain; spinal cord; spinal nerve ligation

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; BIOLOGICAL MARKER; ENZYME INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CISTERNA MAGNA; CONTROLLED STUDY; DOSE RESPONSE; DRUG INHIBITION; ENZYME ACTIVATION; HISTOPATHOLOGY; HYPERALGESIA; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LUMBAR SPINAL CORD; MALE; MEDULLA OBLONGATA; MICROGLIA; NERVE LIGATION; NEUROPATHIC PAIN; NONHUMAN; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SPINAL NERVE;

ANIMALS; ANTIGENS, CD11B; BEHAVIOR, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GLIAL FIBRILLARY ACIDIC PROTEIN; HYPERESTHESIA; IMIDAZOLES; MALE; MEDULLA OBLONGATA; MICROGLIA; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PAIN THRESHOLD; PERIPHERAL NERVOUS SYSTEM DISEASES; PHOSPHOPYRUVATE HYDRATASE; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; SPINAL NERVES; TIME FACTORS;

EID: 43949146604     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2008.03.041     Document Type: Article

References (48)

1. Bian D., Ossipov M.H., Zhong C., Malan Jr. T.P., and Porreca F. Tactile allodynia, but not thermal hyperalgesia, of the hindlimbs is blocked by spinal transection in rats with nerve injury. Neurosci Lett 241 (1998) 79-82
2. Chaplan S.R., Bach F.W., Pogrel J.W., Chung J.M., and Yaksh T.L. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53 (1994) 55-63
3. DeLeo J.A., and Yezierski R.P. The role of neuroinflammation and neuroimmune activation in persistent pain. Pain 90 (2001) 1-6
4. Dixon W.J. Efficient analysis of experimental observations. Annu Rev Pharmacol Toxicol 20 (1980) 441-462
5. Eriksson N.P., Persson J.K., Aldskogius H., and Svensson M. A quantitative analysis of the glial cell reaction in primary sensory termination areas following sciatic nerve injury and treatment with nerve growth factor in the adult rat. Exp Brain Res 114 (1997) 393-404
6. Hains B.C., and Waxman S.G. Activated microglia contribute to the maintenance of chronic pain after spinal cord injury. J Neurosci 26 (2006) 4308-4317
7. Hanisch U.K. Microglia as a source and target of cytokines. Glia 40 (2002) 140-155
8. Hargreaves K., Dubner R., Brown F., Flores C., and Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32 (1988) 77-88
9. Inoue K. Microglial activation by purines and pyrimidines. Glia 40 (2002) 156-163
10. Inoue K. The function of microglia through purinergic receptors: Neuropathic pain and cytokine release. Pharmacol Ther 109 (2006) 210-226
11. Ji R.R., Samad T.A., Jin S.X., Schmoll R., and Woolf C.J. p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia. Neuron 36 (2002) 57-68
12. Jin S.X., Zhuang Z.Y., Woolf C.J., and Ji R.R. p38 Mitogen-activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain. J Neurosci 23 (2003) 4017-4022
13. Kim S.H., and Chung J.M. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 50 (1992) 355-363
14. Kim S.Y., Bae J.C., Kim J.Y., Lee H.L., Lee K.M., Kim D.S., and Cho H.J. Activation of p38 MAP kinase in the rat dorsal root ganglia and spinal cord following peripheral inflammation and nerve injury. Neuroreport 13 (2002) 2483-2486
15. Koistinaho M., and Koistinaho J. Role of p38 and p44/42 mitogen-activated protein kinases in microglia. Glia 40 (2002) 175-183
16. Koistinaho M., Kettunen M.I., Goldsteins G., Keinanen R., Salminen A., Ort M., Bures J., Liu D., Kauppinen R.A., Higgins L.S., and Koistinaho J. Beta-amyloid precursor protein transgenic mice that harbor diffuse A beta deposits but do not form plaques show increased ischemic vulnerability: role of inflammation. Proc Natl Acad Sci U S A 99 (2002) 1610-1615
17. Kreutzberg G.W. Microglia: a sensor for pathological events in the CNS. Trends Neurosci 19 (1996) 312-318
18. Lisney S.J., and Devor M. Afterdischarge and interactions among fibers in damaged peripheral nerve in the rat. Brain Res 415 (1987) 122-136
19. Lopez-Ilasaca M. Signaling from G-protein-coupled receptors to mitogen-activated protein (MAP)-kinase cascades. Biochem Pharmacol 56 (1998) 269-277
20. Ma W., and Quirion R. Partial sciatic nerve ligation induces increase in the phosphorylation of extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) in astrocytes in the lumbar spinal dorsal horn and the gracile nucleus. Pain 99 (2002) 175-184
21. Mielke K., and Herdegen T. JNK and p38 stress kinases: degenerative effectors of signal-transduction-cascades in the nervous system. Prog Neurobiol 61 (2000) 45-60
22. Murashov A.K., Ul Haq I., Hill C., Park E., Smith M., Wang X., Wang X., Goldberg D.J., and Wolgemuth D.J. Crosstalk between p38, Hsp25 and Akt in spinal motor neurons after sciatic nerve injury. Brain Res Mol Brain Res 93 (2001) 199-208
23. Noguchi K., Kawai Y., Fukuoka T., Senba E., and Miki K. Substance P induced by peripheral nerve injury in primary afferent sensory neurons and its effect on dorsal column nucleus neurons. J Neurosci 15 (1995) 7633-7643
24. Ossipov M.H., Bian D., Malan Jr. T.P., Lai J., and Porreca F. Lack of involvement of capsaicin-sensitive primary afferents in nerve-ligation injury induced tactile allodynia in rats. Pain 79 (1999) 127-133
25. Raghavendra V., Tanga F., and DeLeo J.A. Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy. J Pharmacol Exp Ther 306 (2003) 624-630
26. Rincon M., Flavell R.A., and Davis R.A. The JNK and P38 MAP kinase signaling pathways in T cell-mediated immune responses. Free Radic Biol Med 28 (2000) 1328-1337
27. Schafers M., Svensson C.I., Sommer C., and Sorkin L.S. Tumor necrosis factor-alpha induces mechanical allodynia after spinal nerve ligation by activation of p38 MAPK in primary sensory neurons. J Neurosci 23 (2003) 2517-2521
28. Scholz J., and Woolf C.J. Can we conquer pain?. Nat Neurosci 5 Suppl (2002) 1062-1067
29. Seltzer Z., and Devor M. Ephaptic transmission in chronically damaged peripheral nerves. Neurology 29 (1979) 1061-1064
30. Shir Y., and Seltzer Z. A-fibers mediate mechanical hyperesthesia and allodynia and C-fibers mediate thermal hyperalgesia in a new model of causalgiform pain disorders in rats. Neurosci Lett 115 (1990) 62-67
31. Sun H., Ren K., Zhong C.M., Ossipov M.H., Malan T.P., Lai J., and Porreca F. Nerve injury-induced tactile allodynia is mediated via ascending spinal dorsal column projections. Pain 90 (2001) 105-111
32. Sung B., Na H.S., Kim Y.I., Yoon Y.W., Han H.C., Nahm S.H., and Hong S.K. Supraspinal involvement in the production of mechanical allodynia by spinal nerve injury in rats. Neurosci Lett 246 (1998) 117-119
33. Svensson C.I., Schafers M., Jones T.L., Powell H., and Sorkin L.S. Spinal blockade of TNF blocks spinal nerve ligation-induced increases in spinal P-p38. Neurosci Lett 379 (2005) 209-213
34. Tikka T., Fiebich B.L., Goldsteins G., Keinanen R., and Koistinaho J. Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J Neurosci 21 (2001) 2580-2588
35. Tokunaga A., Kondo E., Fukuoka T., Miki K., Dai Y., Tsujino H., and Noguchi K. Excitability of spinal cord and gracile nucleus neurons in rats with chronically injured sciatic nerve examined by c-fos expression. Brain Res 847 (1999) 321-331
36. Tsuda M., Inoue K., and Salter M.W. Neuropathic pain and spinal microglia: a big problem from molecules in "small" glia. Trends Neurosci 28 (2005) 101-107
37. Tsuda M., Mizokoshi A., Shigemoto-Mogami Y., Koizumi S., and Inoue K. Activation of p38 mitogen-activated protein kinase in spinal hyperactive microglia contributes to pain hypersensitivity following peripheral nerve injury. Glia 45 (2004) 89-95
38. Watkins L.R., and Maier S.F. Beyond neurons: evidence that immune and glial cells contribute to pathological pain states. Physiol Rev 82 (2002) 981-1011
39. Watkins L.R., and Maier S.F. Glia: a novel drug discovery target for clinical pain. Nat Rev Drug Discov 2 (2003) 973-985
40. Watkins L.R., Milligan E.D., and Maier S.F. Spinal cord glia: new players in pain. Pain 93 (2001) 201-205
41. Watkins L.R., Milligan E.D., and Maier S.F. Glial activation: a driving force for pathological pain. Trends Neurosci 24 (2001) 450-455
42. Wen Y.R., Suter M.R., Kawasaki Y., Huang J., Pertin M., Kohno T., Berde C.B., Decosterd I., and Ji R.R. Nerve conduction blockade in the sciatic nerve prevents but does not reverse the activation of p38 mitogen-activated protein kinase in spinal microglia in the rat spared nerve injury model. Anesthesiology 107 (2007) 312-321
43. Widmann C., Gibson S., Jarpe M.B., and Johnson G.L. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol Rev 79 (1999) 143-180
44. Woolf C.J., and Mannion R.J. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 353 (1999) 1959-1964
45. Zhuang Z.Y., Gerner P., Woolf C.J., and Ji R.R. ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model. Pain 114 (2005) 149-159
46. Zhuang Z.Y., Kawasaki Y., Tan P.H., Wen Y.R., Huang J., and Ji R.R. Role of the CX3CR1/p38 MAPK pathway in spinal microglia for the development of neuropathic pain following nerve injury-induced cleavage of fractalkine. Brain Behav Immun 21 (2007) 642-651
47. Zhuang Z.Y., Wen Y.R., Zhang D.R., Borsello T., Bonny C., Strichartz G.R., Decosterd I., and Ji R.R. A peptide c-Jun N-terminal kinase (JNK) inhibitor blocks mechanical allodynia after spinal nerve ligation: respective roles of JNK activation in primary sensory neurons and spinal astrocytes for neuropathic pain development and maintenance. J Neurosci 26 (2006) 3551-3560
48. Zimmermann M. Pathobiology of neuropathic pain. Eur J Pharmacol 429 (2001) 23-37